The FDA announced the approval of a variance that allows the sale of Kodak laser projector systems using the company’s laser projection technology to cinema exhibitors without the need for individual site or show operator variances. The allowance offers a step toward delivering brighter 2- and 3-D images that provide higher range and wider color gamut to theaters. In addition, the company said the variance serves as a template to be followed by manufacturers that they license to incorporate the new laser technology. Kodak has worked with laser safety consultants and the FDA to address potential laser safety issues. Its laser projection technology manages the projector output so that it can be considered to be similar to conventional Xenon projection systems. The technology was introduced in September 2010, and the company said it has been well-received by exhibitors, manufacturers, studios and viewers who have seen the demonstrations that feature brighter 3-D viewing and improved image quality. “This laser technology is a significant breakthrough that promises to have a positive ripple effect throughout the cinema world,” said Les Moore, Kodak’s chief operating officer for digital cinema. It is in discussions to license the technology and plans to work toward marketplace implementation within the next two years. For more information, visit: www.kodak.com